Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEI (Paul-Ehrlich Institute) selected for WHO blood/IVDs group:

This article was originally published in Clinica

Executive Summary

Germany's federal office for sera and immunology, the Paul-Ehrlich Institute (PEI), has been selected to join the WHO's co-operation centre for quality assurance in blood products and in vitro diagnostics. The Langen-based unit, which took over responsibility for these area from the former BGA in 1994, will support the WHO in lifting standards "to a level that we have long enjoyed in Germany and Europe", said state secretary at the health ministry Dr Klaus Theo Schroder. Head of the PEI's haematology and transfusion medicine division Professor Rainer Seitz will represent the German institute at the co-operation centre for an initial four-year term.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055939

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel